Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Ain Shams University86 enrolled

Overview

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa to detect efficacy of Tranexamic acid in decreasing blood loss

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

Conditions

Placenta Previa

Interventions

Tranexamic acidDRUG

10 mg/kg body weight will be given with induction of anesthesia by intravenous infusion

Eligibility

Sex: FEMALEHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Term pregnancy (more than 37 weeks of gestation) * Diagnosis of placenta previa was confirmed by ultrasound * The patient hemoglobin percentage is more than 10 mg/dl Exclusion Criteria: * Invading placenta previa diagnosis was confirmed by Doppler ultrasound studies * Emergency lower segment cesarean section * Associated medical comorbidities

Outcomes

Primary Outcomes

intra operative blood loss in ml

Calculation of blood loss during cesarean section in the two groups to detect efficacy of Tranexamic acid in reducing blood loss

Time frame: intraoperative during cesarean section

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.